Cargando…
Commentary: The proinflammatory soluble CD40 ligand is associated with worse outcomes after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390158/ https://www.ncbi.nlm.nih.gov/pubmed/36004125 http://dx.doi.org/10.1016/j.xjon.2021.10.035 |
| _version_ | 1784770591010586624 |
|---|---|
| author | Wong, Michael K.L. Hsin, Michael |
| author_facet | Wong, Michael K.L. Hsin, Michael |
| author_sort | Wong, Michael K.L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9390158 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93901582022-08-23 Commentary: The proinflammatory soluble CD40 ligand is associated with worse outcomes after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension Wong, Michael K.L. Hsin, Michael JTCVS Open Commentary Elsevier 2021-10-26 /pmc/articles/PMC9390158/ /pubmed/36004125 http://dx.doi.org/10.1016/j.xjon.2021.10.035 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Commentary Wong, Michael K.L. Hsin, Michael Commentary: The proinflammatory soluble CD40 ligand is associated with worse outcomes after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension |
| title | Commentary: The proinflammatory soluble CD40 ligand is associated with worse outcomes after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension |
| title_full | Commentary: The proinflammatory soluble CD40 ligand is associated with worse outcomes after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension |
| title_fullStr | Commentary: The proinflammatory soluble CD40 ligand is associated with worse outcomes after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension |
| title_full_unstemmed | Commentary: The proinflammatory soluble CD40 ligand is associated with worse outcomes after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension |
| title_short | Commentary: The proinflammatory soluble CD40 ligand is associated with worse outcomes after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension |
| title_sort | commentary: the proinflammatory soluble cd40 ligand is associated with worse outcomes after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390158/ https://www.ncbi.nlm.nih.gov/pubmed/36004125 http://dx.doi.org/10.1016/j.xjon.2021.10.035 |
| work_keys_str_mv | AT wongmichaelkl commentarytheproinflammatorysolublecd40ligandisassociatedwithworseoutcomesafterpulmonaryendarterectomyinpatientswithchronicthromboembolicpulmonaryhypertension AT hsinmichael commentarytheproinflammatorysolublecd40ligandisassociatedwithworseoutcomesafterpulmonaryendarterectomyinpatientswithchronicthromboembolicpulmonaryhypertension |